Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives
Stefano Gitto, Filippo Schepis, Pietro Andreoné, et al.
Metabolites (2018) Vol. 8, Iss. 1, pp. 17-17
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
José M. Mato, Cristina Alonso, Mazen Noureddin, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 24, pp. 3009-3020
Open Access | Times Cited: 167
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?
Miriam Longo, Marica Meroni, Erika Paolini, et al.
Metabolism (2021) Vol. 117, pp. 154708-154708
Closed Access | Times Cited: 80
San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism
Xiuhai Su, Wenxia Yu, Airu Liu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 42
Association of Nonalcoholic Fatty Liver Disease with Arterial Stiffness and its Metabolomic Profiling in Japanese Community-Dwellers
Aya Hirata, Sei Harada, Miho Iida, et al.
Journal of Atherosclerosis and Thrombosis (2024) Vol. 31, Iss. 7, pp. 1031-1047
Open Access | Times Cited: 7
Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats
Sanna Lensu, Raghunath Pariyani, Elina Mäkinen, et al.
Nutrients (2020) Vol. 12, Iss. 11, pp. 3225-3225
Open Access | Times Cited: 35
Serum aromatic and branched‐chain amino acids associated with NASH demonstrate divergent associations with serum lipids
Vanessa D. de Mello, Ratika Sehgal, Ville Männistö, et al.
Liver International (2020) Vol. 41, Iss. 4, pp. 754-763
Open Access | Times Cited: 34
Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
Qi Zhang, Wenmin Xing, Qiao Wang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 20
New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer
Niama Ezzaidi, Xiang Zhang, Olabisi Oluwabukola Coker, et al.
Cancer Letters (2019) Vol. 459, pp. 186-191
Closed Access | Times Cited: 32
Integration of transcriptomics and metabonomics revealed the protective effects of hemp seed oil against methionine–choline-deficient diet-induced non-alcoholic steatohepatitis in mice
Mengjuan Gong, Hailong Lu, Lixi Li, et al.
Food & Function (2023) Vol. 14, Iss. 4, pp. 2096-2111
Closed Access | Times Cited: 9
Hepatic Mitochondria-Gut Microbiota Interactions in Metabolism-Associated Fatty Liver Disease
Francesco Bellanti, Aurelio Lo Buglio, Gianluigi Vendemiale
Metabolites (2023) Vol. 13, Iss. 3, pp. 322-322
Open Access | Times Cited: 9
Hepatic metabolomics and transcriptomics to study susceptibility to ketosis in response to prepartal nutritional management
Khuram Shahzad, Vincenzo Lopreiato, Yusheng Liang, et al.
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 27
Investigation of steatosis profiles induced by pesticides using liver organ-on-chip model and omics analysis
Rachid Jellali, Sébastien Jacques, Amal Essaouiba, et al.
Food and Chemical Toxicology (2021) Vol. 152, pp. 112155-112155
Open Access | Times Cited: 20
Metabolic biomarkers related to cardiac dysfunction in metabolic-dysfunction-associated fatty liver disease: a cross-sectional analysis
Abdulrahman Ismaiel, Mihail Spînu, Carmen Socaciu, et al.
Nutrition and Diabetes (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing
Mengjuan Gong, Cai-Yan Zhu, Zhongjie Zou, et al.
Journal of Pharmaceutical and Biomedical Analysis (2021) Vol. 197, pp. 113964-113964
Closed Access | Times Cited: 17
Bile acid dysmetabolism in the gut‐microbiota‐liver axis under hepatitis C virus infection
Takako Inoue, Yui Funatsu, Masaya Ohnishi, et al.
Liver International (2021) Vol. 42, Iss. 1, pp. 124-134
Closed Access | Times Cited: 16
Untargeted metabolomics reveals plasma metabolites predictive of ectopic fat in pancreas and liver as assessed by magnetic resonance imaging: the TOFI_Asia study
Zhanxuan E. Wu, Karl Fraser, Marlena C. Kruger, et al.
International Journal of Obesity (2021) Vol. 45, Iss. 8, pp. 1844-1854
Open Access | Times Cited: 14
The modulation of Luffa cylindrica (L.) Roem supplementation on gene expression and amino acid profiles in liver for alleviating hepatic steatosis via gut microbiota in high-fat diet-fed mice: insight from hepatic transcriptome analysis
Lu Zhang, Pengpu Wang, Mengxuan Shi, et al.
The Journal of Nutritional Biochemistry (2020) Vol. 80, pp. 108365-108365
Closed Access | Times Cited: 14
Serum metabolomic profiling reveals an increase in homocitrulline in Chinese patients with nonalcoholic fatty liver disease: a retrospective study
Yarong Yang, Zexin Huang, Zhao Yang, et al.
PeerJ (2021) Vol. 9, pp. e11346-e11346
Open Access | Times Cited: 13
Metabolomic analysis shows dysregulation in amino acid and NAD+ metabolism in palmitate treated hepatocytes and plasma of non-alcoholic fatty liver disease spectrum
Savera Aggarwal, Vipin K. Yadav, Rakhi Maiwall, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 643, pp. 129-138
Closed Access | Times Cited: 9
Integrated multi-omics and bioinformatic methods to reveal the mechanisms of sinomenine against diabetic nephropathy
Yan Li, Lei Wang, Jimin Zhang, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Metabonomic Profile of Macrosteatotic Allografts for Orthotopic Liver Transplantation in Patients With Initial Poor Function: Mechanistic Investigation and Prognostic Prediction
Zhengtao Liu, Hai Zhu, Wenchao Wang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 8
CE with Cu2+ ions and 2-hydroxypropyl-β-cyclodextrin additives for the investigation of amino acids composition of the culture medium in a cellular model of non-alcoholic fatty liver disease
D. V. Makeeva, Tatiana Sall, D. O. Moskvichev, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 213, pp. 114663-114663
Closed Access | Times Cited: 5
Clinical Phenotyping and the Application of Precision Medicine in MAFLD
Saad Saffo, Albert Do
Clinical Liver Disease (2022) Vol. 19, Iss. 6, pp. 227-233
Open Access | Times Cited: 5
Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model
Joselyn Natasha Allen, Jingtao Zhang, Michael D. Quickel, et al.
Journal of Proteome Research (2018) Vol. 17, Iss. 9, pp. 3268-3280
Open Access | Times Cited: 6
RETRACTED: The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
Lucia Carulli, Giulia Zanca, Filippo Schepis, et al.
Metabolites (2019) Vol. 9, Iss. 2, pp. 25-25
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top